ARCHIVES

FASEB Delivers Its Recommendations For Federal Research Funding in 2013

This article is from The Cancer Letter archive.

Vol. 38 No. 05 | February 3, 2012

Download PDF Visit The Full Archive

Related Articles

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003

In Brief: UCSD Recruits Mitchell From USC; Wade Wins Policy Fellowship; ASCO Honors Burchenal

July 15, 1994

FDA Approves BMS’s Yervoy For Metastatic Melanoma

March 25, 2011

DeVita Accepts “Chop Lie” Cancer Control Elements In CCOP; RFA Delays Until After May NCAB Meeting

March 12, 1982